PND89 PERSISTENCE TO ORAL AND INJECTABLE MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES

Authors :: E. Rusli
B. Lempernesse
J. Ransom
M. Berger
A. Galaznik
A. Shilnikova
Source :: Value in Health. 22:S287
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Persistence (psychology)
business.industry
Health Policy
Multiple sclerosis
Immunology
Public Health, Environmental and Occupational Health
medicine
Disease
medicine.disease
business

Tools